Susquehanna International Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.7M | Sell |
329,000
-371,600
| -53% | -$23.6M | ﹤0.01% | 2120 |
|
|
2025
Q4 | $44.5M | Buy |
700,600
+264,400
| +61% | +$16.4M | 0.01% | 1462 |
|
|
2025
Q3 | $24M | Buy |
436,200
+224,300
| +106% | +$9.24M | ﹤0.01% | 2015 |
|
|
2025
Q2 | $7M | Sell |
211,900
-56,300
| -21% | -$1.96M | ﹤0.01% | 3371 |
|
|
2025
Q1 | $10.8M | Buy |
268,200
+22,700
| +9% | +$1.04M | ﹤0.01% | 2431 |
|
|
2024
Q4 | $11.5M | Sell |
245,500
-75,000
| -23% | -$3.9M | ﹤0.01% | 2482 |
|
|
2024
Q3 | $16.9M | Buy |
320,500
+30,700
| +11% | +$1.71M | ﹤0.01% | 1998 |
|
|
2024
Q2 | $15.7M | Sell |
289,800
-655,900
| -69% | -$39.6M | ﹤0.01% | 1988 |
|
|
2024
Q1 | $66.3M | Sell |
945,700
-1,030,000
| -52% | -$79.7M | 0.01% | 866 |
|
|
2023
Q4 | $165M | Buy |
1,975,700
+1,754,600
| +794% | +$63.5M | 0.03% | 472 |
|
|
2023
Q3 | $6.51M | Buy |
221,100
+202,300
| +1,076% | +$6.74M | ﹤0.01% | 3121 |
|
|
2023
Q2 | $613K | Sell |
18,800
-12,400
| -40% | -$459K | ﹤0.01% | 7833 |
|
|
2023
Q1 | $1.1M | Sell |
31,200
-13,800
| -31% | -$563K | ﹤0.01% | 6560 |
|
|
2022
Q4 | $2.06M | Buy |
45,000
+30,800
| +217% | +$1.33M | ﹤0.01% | 4645 |
|
|
2022
Q3 | $688K | Sell |
14,200
-4,400
| -24% | -$212K | ﹤0.01% | 7611 |
|
|
2022
Q2 | $731K | Sell |
18,600
-5,800
| -24% | -$234K | ﹤0.01% | 7298 |
|
|
2022
Q1 | $898K | Sell |
24,400
-1,000
| -4% | -$35.5K | ﹤0.01% | 7399 |
|
|
2021
Q4 | $1.16M | Buy |
25,400
+3,300
| +15% | +$127K | ﹤0.01% | 6905 |
|
|
2021
Q3 | $790K | Sell |
22,100
-116,700
| -84% | -$3.44M | ﹤0.01% | 8168 |
|
|
2021
Q2 | $2.75M | Buy |
138,800
+86,900
| +167% | +$2.04M | ﹤0.01% | 5219 |
|
|
2021
Q1 | $1.21M | Buy |
51,900
+27,000
| +108% | +$577K | ﹤0.01% | 7222 |
|
|
2020
Q4 | $517K | Sell |
24,900
-388,300
| -94% | -$7.1M | ﹤0.01% | 8213 |
|
|
2020
Q3 | $8.95M | Buy |
413,200
+329,700
| +395% | +$7.71M | ﹤0.01% | 2316 |
|
|
2020
Q2 | $1.97M | Sell |
83,500
-55,100
| -40% | -$1.03M | ﹤0.01% | 4528 |
|
|
2020
Q1 | $1.63M | Buy |
138,600
+25,700
| +23% | +$328K | ﹤0.01% | 4344 |
|
|
2019
Q4 | $1.2M | Buy |
112,900
+83,500
| +284% | +$858K | ﹤0.01% | 5177 |
|
|
2019
Q3 | $335K | Sell |
29,400
-21,300
| -42% | -$267K | ﹤0.01% | 8061 |
|
|
2019
Q2 | $570K | Buy |
50,700
+28,200
| +125% | +$272K | ﹤0.01% | 7012 |
|
|
2019
Q1 | $182K | Sell |
22,500
-36,000
| -62% | -$265K | ﹤0.01% | 7933 |
|
|
2018
Q4 | $370K | Buy |
+58,500
| New | +$429K | ﹤0.01% | 6614 |
|
|
2018
Q3 | – | Sell |
-14,400
| Closed | -$120K | – | 9363 |
|
|
2018
Q2 | $120K | Sell |
14,400
-38,800
| -73% | -$323K | ﹤0.01% | 8965 |
|
|
2018
Q1 | $383K | Sell |
53,200
-31,600
| -37% | -$271K | ﹤0.01% | 7177 |
|
|
2017
Q4 | $691K | Sell |
84,800
-28,000
| -25% | -$318K | ﹤0.01% | 5979 |
|
|
2017
Q3 | $1.64M | Buy |
112,800
+8,500
| +8% | +$116K | ﹤0.01% | 4289 |
|
|
2017
Q2 | $1.26M | Buy |
104,300
+80,300
| +335% | +$1.12M | ﹤0.01% | 4788 |
|
|
2017
Q1 | $308K | Buy |
24,000
+13,900
| +138% | +$162K | ﹤0.01% | 7290 |
|
|
2016
Q4 | $123K | Sell |
10,100
-26,900
| -73% | -$285K | ﹤0.01% | 8977 |
|
|
2016
Q3 | $340K | Buy |
37,000
+5,200
| +16% | +$54.3K | ﹤0.01% | 6725 |
|
|
2016
Q2 | $302K | Sell |
31,800
-41,200
| -56% | -$338K | ﹤0.01% | 6939 |
|
|
2016
Q1 | $515K | Buy |
73,000
+47,500
| +186% | +$347K | ﹤0.01% | 6348 |
|
|
2015
Q4 | $267K | Buy |
25,500
+12,400
| +95% | +$122K | ﹤0.01% | 7910 |
|
|
2015
Q3 | $88K | Sell |
13,100
-22,400
| -63% | -$153K | ﹤0.01% | 9192 |
|
|
2015
Q2 | $239K | Buy |
35,500
+1,400
| +4% | +$9.18K | ﹤0.01% | 8968 |
|
|
2015
Q1 | $231K | Sell |
34,100
-12,000
| -26% | -$89.6K | ﹤0.01% | 8420 |
|
|
2014
Q4 | $369K | Sell |
46,100
-18,600
| -29% | -$79.8K | ﹤0.01% | 7781 |
|
|
2014
Q3 | $228K | Sell |
64,700
-151,500
| -70% | -$636K | ﹤0.01% | 8444 |
|
|
2014
Q2 | $1.03M | Sell |
216,200
-128,400
| -37% | -$784K | ﹤0.01% | 5988 |
|
|
2014
Q1 | $3.27M | Buy |
344,600
+232,400
| +207% | +$2.1M | ﹤0.01% | 3504 |
|
|
2013
Q4 | $729K | Sell |
112,200
-29,100
| -21% | -$191K | ﹤0.01% | 6075 |
|
|
2013
Q3 | $1.07M | Buy |
+141,300
| New | +$1.52M | ﹤0.01% | 5156 |
|
Other funds holding CYTK
VPM
VCM
ACA
Susquehanna International Group's CYTK Position: Q1 2026 in Review
Susquehanna International Group increased its Cytokinetics (CYTK) stake by 19% in Q1 2026, buying an estimated $9.24M and bringing the position to 898,951 shares worth $59.2M. The position accounts for 0.01% of the portfolio, ranked #1161.
Susquehanna International Group first reported a position in CYTK in Q3 2013 and has held it in 42 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.
- Susquehanna International Group held 898,951 shares of Cytokinetics worth $59.2M as of Q1 2026.
- Susquehanna International Group bought 145,334 Cytokinetics shares in Q1 2026, an estimated $9.24M.
- Cytokinetics made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1161 holding.
- Susquehanna International Group first reported a position in Cytokinetics in Q3 2013 and has held it in 42 quarters since.
- 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.